Also the point of the quarterly is to highlight the key outcomes for the quarter. And that was the launch of ptx-100 phase 1b. I really don’t think there’s anything to worry about in relation to ptx-200 - there was just nothing to really report for the quarter.
don’t forget also the breast cancer trial finished recruiting in July
Ann: September 2019 Appendix 4C - Quarterly, page-26
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.7¢ | 4.5¢ | $62.18K | 1.359M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53690 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 65165 | 2 |
View Market Depth
| Last trade - 15.38pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
0.000 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 4.6¢ | 4.5¢ | 425488 | ||
| Last updated 15.38pm 11/06/2024 ? | |||||
| PTX (ASX) Chart |